Lataa...

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer

Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Matthew G. Field, H. Culver Boldt, Taher Abu Hejleh, Elaine M. Binkley
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2022-06-01
Sarja:American Journal of Ophthalmology Case Reports
Aiheet:
Linkit:http://www.sciencedirect.com/science/article/pii/S2451993622002055
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!